Global contract development and manufacturing organization (CDMO), Sterling Pharma Solutions, is investing $1.5 million into a phased expansion of its U.S. facility in North Carolina.   The investment follows the acquisition of the former U.S. CiVentiChem site earlier this year. Over the next three years, the company plans to expand the cGMP production suites, add a non-GMP scale-up production facility, expand its quality control (QC) laboratory and increase the site’s R&D capacity.   “The N...